ArticleOncotarget2016

Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.

Xin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.